Cuba’s Finlay Vaccine Institute said late on Friday it has signed an accord with Iran’s Pasteur Institute to collaborate on the production of coronavirus vaccine.
Iran launched human trials of its first domestic COVID-19 vaccine candidate late last month, while Cuba has four candidates currently in human trials.
Once its most advanced candidate, Soberana (Sovereign) 2, has completed Phase II trials which started on Dec. 22, it will be tested in Phase III trials in around 150,000 people in Havana, officials have said.
Cuba’s Finlay Vaccine Institute said late on Friday it has signed an accord with Iran’s Pasteur Institute to collaborate on testing of Soberana 2.
“This synergy will enable both countries to advance more rapidly in the immunization against the SARS-CoV-2 virus,” it said on its Twitter account.
Cuba says several countries have expressed interest in its coronavirus vaccines but this is the first such accord it has reached.